case report aspiration semaglutide anesthesia 2023 Aspiration risk with glucagon‐like peptide 1 (GLP‐1) agonists - Marroquin‐Harris - 2023 - Anaesthesia

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study

21.02

★★★★☆4.8 (126)

Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists

25.25

★★★★★4.9 (98)

Concerns have been raised about whether the delayed gastric emptying caused by GLP-1–based medications might jeopardize patient safety during procedures that require sedation. A randomized trial takes a closer look

22.60

★★★★★5.0 (157)

Delayed gastric emptying: an unwanted effect of glucagon like peptide 1 agonists in the perioperative setting – The Anaesthesia Collective

21.88

★★★★★4.7 (84)

Aspiration risk tops anesthesiologists' concerns for patients on GLP-1 medications » Department of Anesthesiology » College of Medicine » University of Florida

26.47

★★★★★4.9 (203)

Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice - Milder - 2024 - Anaesthesia

27.09

★★★★★5.0 (176)

Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia

21.69

★★★★★4.8 (132)